Patent · US Active

(R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition

US7294721B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Guenter Linz · Mittelbiberach, DE
Peter Sieger · Mittelbiberach, DE
Gunnar Schreiner · Biberach, DE
Werner Rall · Mittelbiberach, DE
Rolf Schmid · Gelterkinden, CH

Key dates

Filing date	Dec 13, 2006
Grant date	Nov 13, 2007
Priority date	—
Expiry date	Dec 13, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Crystalline forms of the compounds (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole and the monohydrochloride thereof, processes for the preparation thereof and the use thereof as pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.